Ubs Asset Management Americas Inc Immunome Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Immunome Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 186,698 shares of IMNM stock, worth $2.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
186,698
Previous 78,344
138.31%
Holding current value
$2.31 Million
Previous $527,000
229.41%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding IMNM
# of Institutions
148Shares Held
66.5MCall Options Held
44.9KPut Options Held
4.24M-
T. Rowe Price Investment Management, Inc. Baltimore, MD8.28MShares$102 Million0.05% of portfolio
-
Redmile Group, LLC San Francisco, CA4.87MShares$60.3 Million5.51% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.69MShares$58 Million0.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.52MShares$56 Million0.0% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.08MShares$50.5 Million3.27% of portfolio
About Immunome Inc.
- Ticker IMNM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 12,127,400
- Market Cap $150M
- Description
- Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...